Condition
Adult Malignant Meningioma
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
2 treatments under study, led by Ifosfamide
Related Conditions
Often studied with 18 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Phase 1 (1)
Phase 2 (1)
Trial Status
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Ifosfamide1
- Sterotactic Radiosurgery1
Active Sponsors
- Eastern Cooperative Oncology Group1
- SWOG Cancer Research Network1
- National Cancer Institute (NCI)1
- National Institutes of Health Clinical Center (CC)1
Top Investigators
National Cancer Institute (NCI)
Neurological Clinic
University of Miami Sylvester Comprehensive Cancer Center
Related Conditions
- Adult Craniopharyngioma1
- Adult Central Nervous System Germ Cell Tumor1
- Adult Rhabdomyosarcoma1
- Adult Leiomyosarcoma1
- Mixed Gliomas1